Home › NDC Lookup › RxCUI directory › RxCUI 2475340

250 ML norepinephrine 0.032 MG/ML Injection — RxCUI 2475340

RxNorm drug concept · Semantic clinical drug
RxCUI 2475340 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2475340
Official name250 ML norepinephrine 0.032 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnorepinephrine (as bitartrate) 8 MG per 250 ML Injection; norepinephrine bitartrate 8 MG in 250 ML Injection
FDA products mapped13
Package NDCs mapped13
Reported Medicaid activity (SDUD)651 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Norepinephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Norepinephrine is used when someone's blood pressure drops to a dangerously low level — low enough to put the brain, heart, and other organs at risk. It works very quickly to bring...
  • Why is my loved one receiving norepinephrine in the ICU?
  • The medical team will be watching closely for a few important things. The biggest concern is that if the IV leaks, norepinephrine can damage the tissue around the site — so any pai...
  • Can norepinephrine cause any serious problems I should watch for?
📖 Read our full Norepinephrine guide →

🕸️ Concept Web — How 250 ML norepinephrine 0.032 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 250 ML norepinephrine 0.032 MG/ML Injection RxCUI 2475340

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Norepinephrine 7512
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Norepinephrine Injection 1745276
    • Norepinephrine Injectable Product 1159845
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Norepinephrine 0.032 MG/ML 2475339

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Norepinephrine 0.032 MG/ML SCDC · 2475339
  • Norepinephrine Injection SCDF · 1745276
  • Norepinephrine Injectable Product SCDG · 1159845

📦 FDA Products & Package NDCs

13 products · 13 package NDCs
13 package NDCs map to RxCUI 2475340 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00338-0040-20 20 BAG in 1 CARTON (0338-0040-20) / 250 mL in 1 BAG NOREPINEPHRINE BITARTRATE Baxter Healthcare Corporation 2026-02-06
00338-0042-20 20 BAG in 1 CARTON (0338-0042-20) / 250 mL in 1 BAG NOREPINEPHRINE BITARTRATE Baxter Healthcare Corporation 2026-02-06
00338-0108-20 20 CONTAINER in 1 CARTON (0338-0108-20) / 250 mL in 1 CONTA... NOREPINEPHRINE BITARTRATE Baxter Healthcare Corporation 2021-01-15
00338-0112-20 20 BAG in 1 CARTON (0338-0112-20) / 250 mL in 1 BAG NOREPINEPHRINE BITARTRATE Baxter Healthcare Corporation 2021-01-15
00338-0116-20 20 BAG in 1 CARTON (0338-0116-20) / 250 mL in 1 BAG NOREPINEPHRINE BITARTRATE Baxter Healthcare Corporation 2023-11-21
00338-0128-20 20 BAG in 1 CARTON (0338-0128-20) / 250 mL in 1 BAG NOREPINEPHRINE BITARTRATE Baxter Healthcare Corporation 2026-02-06
44567-0640-10 10 BAG in 1 CARTON (44567-640-10) / 250 mL in 1 BAG (44567-... NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE WG Critical Care, LLC 2022-10-31
44567-0641-10 10 BAG in 1 CARTON (44567-641-10) / 250 mL in 1 BAG (44567-... NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE WG Critical Care, LLC 2022-10-31
44567-0642-10 10 BAG in 1 CARTON (44567-642-10) / 250 mL in 1 BAG (44567-... NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE WG Critical Care, LLC 2022-10-31
44567-0643-10 10 BAG in 1 CARTON (44567-643-10) / 250 mL in 1 BAG (44567-... NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE WG Critical Care, LLC 2025-10-01
81298-9655-03 10 POUCH in 1 BOX (81298-9655-3) / 1 BAG in 1 POUCH (81298-... Norepinephrine Long Grove Pharmaceuticals, LLC 2024-02-02
81298-9658-03 10 POUCH in 1 BOX (81298-9658-3) / 1 BAG in 1 POUCH (81298-... Norepinephrine Long Grove Pharmaceuticals, LLC 2024-02-02
81298-9659-03 10 POUCH in 1 BOX (81298-9659-3) / 1 BAG in 1 POUCH (81298-... Norepinephrine Long Grove Pharmaceuticals, LLC 2024-02-02
Observed labelers: Baxter Healthcare Corporation (6) · WG Critical Care, LLC (4) · Long Grove Pharmaceuticals, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.